from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3332/nagA

LFCtreatmentdescriptionclass of inhibitor

0.141

Amikacinug/mL Amikacintranslation

0.016

Cap5-10ug/mL Capreomycintranslation

0.213

Rox10-50 ug/mL Roxithromycintranslation

-0.126

SM2-5 ug/mL Streptomycintranslation

0.439

Tet5-10 ug/mL Tetracyclinetranslation

0.525

Rif0.2-5ug/mL Rifampicintranscription

1.193

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.729

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.761

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.161

CPZ10-50 ug/mL Chlorpromazinerespiration

0.495

Clofazimine10-13 ug/mL Clofaziminerespiration

0.184

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.636

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.529

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.110

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.220

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.214

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.615

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.701

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.630

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.432

KCN5-20 ug/mL Potassium cyaniderespiration

-0.362

NaN30.2-2 mM Sodium aziderespiration

0.684

Nigericin50 uM Nigericinrespiration

0.093

TRC10-150 ug/mL Triclosanrespiration

-1.035

TRZ10-25 ug/mL Thioridazinerespiration

-0.835

Valinomycin0.5-10 uM Valinomycinrespiration

-1.807

ZnSO42 mM ZnSO4respiration

1.163

menadione6-10 ug/mL Menadionerespiration

0.501

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.151

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.420

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.274

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.073

NRP_1Non-replicating persistence stage 1dosRassociated

-0.053

Amp0.2mg/mL AmpicillincellWall

0.159

Cephalexin20-100 ug/mL CephalexincellWall

-0.195

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.054

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.018

EMB10-20 ug/mL EthambutolcellWall

-0.442

Eta12-40 ug/mL EthionamidecellWall

-1.144

INH0.2-0.4 ug/mL IsoniazidcellWall

0.066

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.501

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.079

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.122

BZA0.12 mg/mL BenzamidearomaticAmides

0.260

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.202

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.564

H2O24 mM hydrogen peroxideDNAdamaging

0.730

Levo10 ug/mL LevofloxacinDNAdamaging

0.254

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.650

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.360

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.041

UVUV-irradiationDNAdamaging

0.650

ARP41-4 ug/mL Antitubercular compound ARP4?

0.306

Antimycin12.5-50 ug/mL Antimycin A?

0.415

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.328

PA_110-50 ug/mL Antitubercular compound PA-1?

0.244

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.361

PA8240.2-2 ug/mL PA-824?

-0.989

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.241

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.601

Verapamil50 uM Verapamil?

0.932

mercaptoethanol2 mM 2-Mercaptoethanol?

1.099

methoxatin10-20 ug/mL Methoxatin?